GlassScriptPhysician profile
Juan Estrada
NPI 1598833808
$7,397.00
in general payments reported to CMS, 2019-2025
15 companies · $1,626 in 2025
The $1,626 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $534 · 2021: $387 · 2022: $2,683 · 2023: $593 · 2024: $1,060 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,417 · Travel and Lodging: $782 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,416.64 |
| Travel and Lodging | $781.71 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,655.05 | 2022-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Boston Scientific Corporation | $1,547.13 | 2019-2025 | Watchman Flx, Watchman Access System |
| Medtronic Vascular, INC. | $718.09 | 2019-2020 | |
| Biosense Webster, INC. | $363.10 | 2022-2024 | Carto 3 |
| Abbott Laboratories | $279.04 | 2024-2025 | Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $224.94 | 2019 | |
| Ucb, INC. | $202.23 | 2024-2025 | Bimzelx |
| Atricure, INC. | $138.88 | 2021 | |
| Janssen Biotech, INC. | $80.00 | 2023 | Tremfya |
| Pfizer INC. | $50.91 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.56 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $25.40 | 2024 | |
| Kyowa Kirin, INC. | $23.95 | 2023 | Poteligeo |
| Kerecis Limited | $22.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Altathera Pharmaceuticals LLC | $16.09 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Estrada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.